ASP Isotopes News
News
0
Ticker
ASPI
ISIN
US00218A1051
ASP Isotopes Eulerpool News
ASP Isotopes Stock News
ASP Isotopes is being monitored by journalists and investors worldwide. We gather the latest ASP Isotopes news here.
- January 29·Benzinga
- January 8·Yahoo
- January 7·Yahoo
- December 2·Benzinga
- November 22·SeekingAlpha
- October 29·Yahoo
- October 22·Yahoo
- October 19·Yahoo
- October 15·Yahoo
- October 14·Yahoo
- October 13·Yahoo
- October 10·Benzinga
- October 7·Yahoo
- October 3·Yahoo
- September 30·Yahoo
- September 29·Yahoo
- September 24·Yahoo
- September 4·SeekingAlpha
- September 2·Yahoo
- September 2·Benzinga
ASP Isotopes Stock Press Releases
ASP Isotopes regularly publishes news on the company's website that are relevant for investors.
ASP Isotopes News 2026
This page contains all current news, analysis and press releases for ASP Isotopes stock (ASPI, ISIN: US00218A1051). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at ASP Isotopes.
ASP Isotopes Stock
ASP Isotopes ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications.